Monitoring aberrant 53BP1, particularly in conjunction with Ki67, may enhance the predictive accuracy for lymph node metastasis and vascular invasion, ultimately aiding the prognosis and management of patients with HPSCC. Here, TP53BP1 is linked to metastatic malignant neoplasm in the lymph nodes.